David Chatenet
Impact in
- Pharmacology top 1%
- Apelin-related biomedical research
-
- Hormonal Regulation and Hypertension
Papers in
- Surgery 37
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 37
- Pharmacology 31
- Apelin-related biomedical research 29
- Co-authors
- Alain Fournier (31 shared papers)Jérôme Leprince (20 shared papers)Myriam Létourneau (31 shared papers)Hubert Vaudry (16 shared papers)David Vaudry (10 shared papers)Hubert Vaudry (8 shared papers)Elizabeth Scalbert (7 shared papers)Christophe Dubessy (7 shared papers)
In The Last Decade
David Chatenet
79 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 84
- Pharmacology 639
- Endocrinology, Diabetes and Metabolism 461
- Cellular and Molecular Neuroscience 462
- Surgery 867
- Cardiology and Cardiovascular Medicine 330
Countries citing papers authored by David Chatenet
This map shows the geographic impact of David Chatenet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chatenet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chatenet more than expected).
Fields of papers citing papers by David Chatenet
This network shows the impact of papers produced by David Chatenet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chatenet. The network helps show where David Chatenet may publish in the future.
Co-authors
The 25 scholars most cited alongside David Chatenet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 87 | |
| 2 | 2010 | 84 | |
| 3 | 2014 | 79 | |
| 4 | 2003 | 71 | |
| 5 | 2006 | 70 | |
| 6 | 2007 | 69 | |
| 7 | 2019 | 56 | |
| 8 | 2006 | 56 | |
| 9 | 2010 | 48 | |
| 10 | 2006 | 48 | |
| 11 | 2005 | 47 | |
| 12 | 2017 | 46 | |
| 13 | 2004 | 45 | |
| 14 | 2015 | 45 | |
| 15 | 2013 | 42 | |
| 16 | 2007 | 42 | |
| 17 | 2013 | 41 | |
| 18 | 2010 | 36 | |
| 19 | 2004 | 34 | |
| 20 | 2011 | 34 |
About David Chatenet
David Chatenet is a scholar working on Surgery, Pharmacology, Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 83 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cardiovascular, Neuropeptides, and Oxidative Stress Research (37 papers), Apelin-related biomedical research (29 papers), Neuropeptides and Animal Physiology (25 papers), Hormonal Regulation and Hypertension (21 papers), Peptidase Inhibition and Analysis (10 papers), Cardiovascular Disease and Adiposity (9 papers), Galectins and Cancer Biology (8 papers) and Receptor Mechanisms and Signaling (8 papers). The work is most often cited by research in Pharmacology (639 citations), Endocrinology, Diabetes and Metabolism (461 citations), Cellular and Molecular Neuroscience (462 citations), Surgery (867 citations) and Cardiology and Cardiovascular Medicine (330 citations). David Chatenet has collaborated with scholars based in Canada, France and Italy. Frequent co-authors include Alain Fournier, Jérôme Leprince, Myriam Létourneau, Hubert Vaudry, David Vaudry, Hubert Vaudry, Elizabeth Scalbert, Christophe Dubessy, Hervé Tostivint and Terence E. Hébert. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology, Peptides, Journal of Neurochemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.